The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection

被引:202
作者
Crowe, S
Zhu, TF
Muller, WA
机构
[1] Macfarlane Burnet Inst Med Res & Publ Hlth Ltd, AIDS Pathogenesis & Clin Res Programme, Melbourne, Vic 3001, Australia
[2] Univ Washington, Sch Med, Lab Med & Microbiol, Seattle, WA 98195 USA
[3] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, Ithaca, NY 14853 USA
关键词
monocyte; macrophage; HIV-1; reservoir; persistence; trafficking; eradication; highly active antiretroviral therapy;
D O I
10.1189/jlb.0503204
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cellular viral reservoirs and anatomic sanctuary sites allow continuing HIV-1 replication in patients with suppressed plasma viremia who are receiving highly active antiretroviral therapy and prevent eradication of HIV-1 by these regimens. Cells of macrophage lineage, including monocytes subsets within the blood, play a role in HIV-1 persistence. Evidence of sequence evolution in blood monocytes, in comparison to resting CD4(+) T cells, demonstrates their distinct contribution to Plasma viremia. There is evidence to suggest that a specific monocyte subset, of CD141oCD16hi phenotype, is more susceptible to HIV-1 infection than the majority of blood monocytes. Trafficking of monocytes through various tissues following their emigration from the bloodstream allows these cells to differentiate into tissue macrophages, or potentially to egress from the tissues as migratory dendritic cells. This review provides an evaluation of the contribution of monocytes to HIV-1 persistence and the HIV-1 reservoir, essential for the effective design of therapeutic eradication strategies. J. Leukoc. Biol. 74: 635-641; 2003.
引用
收藏
页码:635 / 641
页数:7
相关论文
共 107 条
[1]  
Ancuta P, 2000, EUR J IMMUNOL, V30, P1872, DOI 10.1002/1521-4141(200007)30:7<1872::AID-IMMU1872>3.0.CO
[2]  
2-2
[3]   Macrophages and HIV infection:: therapeutical approaches toward this strategic virus reservoir [J].
Aquaro, S ;
Caliò, R ;
Balzarini, J ;
Bellocchi, MC ;
Garaci, E ;
Perno, CF .
ANTIVIRAL RESEARCH, 2002, 55 (02) :209-225
[4]   The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF [J].
Belge, KU ;
Dayyani, F ;
Horelt, A ;
Siedlar, M ;
Frankenberger, M ;
Frankenberger, B ;
Espevik, T ;
Ziegler-Heitbrock, L .
JOURNAL OF IMMUNOLOGY, 2002, 168 (07) :3536-3542
[5]  
Bellingan GJ, 1996, J IMMUNOL, V157, P2577
[6]   Cytokine production precedes the expansion of CD14(+)CD16(+) monocytes in human sepsis: A case report of a patient with self-induced septicemia [J].
Blumenstein, M ;
Boekstegers, P ;
Fraunberger, P ;
Andreesen, R ;
ZieglerHeitbrock, HWL ;
FingerleRowson, G .
SHOCK, 1997, 8 (01) :73-75
[7]   Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection [J].
Cavert, W ;
Notermans, DW ;
Staskus, K ;
Wietgrefe, SW ;
Zupancic, M ;
Gebhard, K ;
Henry, K ;
Zhang, ZQ ;
Mills, R ;
McDade, H ;
Goudsmit, J ;
Danner, SA ;
Haase, AT .
SCIENCE, 1997, 276 (5314) :960-964
[8]   Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy [J].
Chun, TW ;
Davey, RT ;
Ostrowski, M ;
Justement, JS ;
Engel, D ;
Mullins, JI ;
Fauci, AS .
NATURE MEDICINE, 2000, 6 (07) :757-761
[9]   Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].
Chun, TW ;
Stuyver, L ;
Mizell, SB ;
Ehler, LA ;
Mican, JAM ;
Baseler, M ;
Lloyd, AL ;
Nowak, MA ;
Fauci, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197
[10]  
Cosenza MA, 2002, BRAIN PATHOL, V12, P442, DOI 10.1111/j.1750-3639.2002.tb00461.x